CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancerMalachi Griffith, Obi L. Griffith, Kilannin Krysiak et al.|Nature Genetics|2017Cited by 673
Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket studyFunda Meric‐Bernstam, John D. Hainsworth, Herbert I. Hurwitz et al.|The Lancet Oncology|2019Cited by 564
Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interfaceXuewu Zhang, John Kuriyan, Kerry A. Pickin et al.|Nature|2007Cited by 351
Analysis of the Role of the C-Terminal Tail in the Regulation of the Epidermal Growth Factor ReceptorErika Kovács, John Kuriyan, Qi Wang et al.|Molecular and Cellular Biology|2015Cited by 91
Quantitative Proteomics with siRNA Screening Identifies Novel Mechanisms of Trastuzumab Resistance in HER2 Amplified Breast CancersAlaina Boyer, Ron Bose|Molecular & Cellular Proteomics|2012Cited by 47